Skip to content
Disclosery

13F-HR/A filed by BML Capital Management, LLC

BML Capital Management, LLC filed this 13F-HR/A for the quarter ended 2024-03-31, filed 2024-04-24, with 32 holding rows worth $151,657,396.

Accession
0001754960-24-000178
Filer
CIK 1616824
Filed
2024-04-24
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2024

A holdings report, amendment of type restatement, 32 entries on the cover page, a total value of $151,657,396 stated on the cover page (in dollars after the unit check, H1), rows summing to $151,657,396 with VALUE read as dollars as filed, 13F file number 028-22948. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
iShares 0-3 Month Treasury Bond ETF46436E718SHS270,000$27,191,700dollars as filed
ATEA PHARMACEUTICALS INC04683R106COMMON STOCK5,536,710$22,368,308dollars as filed
SPDR Bloomberg 1-3 Month T-Bill ETF78468R663SHS200,000$18,360,000dollars as filed
ADVERUM BIOTECHNOLOGIES INC00773U207COM NEW833,117$11,780,274dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock9,395,934$11,650,958dollars as filed
CYTEIR THERAPEUTICS INC23284P103COMMON3,654,053$10,998,700dollars as filed
CLIMB BIO INC28658R106COMMON STOCK2,193,742$6,010,853dollars as filed
TECTONIC THERAPEUTIC INC COM05455M100Stock4,001,627$5,122,083dollars as filed
Instil Bio Inc45783C200COM NEW348,735$3,766,338dollars as filed
RENEO PHARMACEUTICALS INC75974E103COM2,177,913$3,615,336dollars as filed
CONNECT BIOPHARMA HLDGS LTD207523101SHS2,061,338$3,586,728dollars as filed
DESIGN THERAPEUTICS INC25056L103COM879,478$3,544,296dollars as filed
ATHIRA PHARMA INC04746L104COM900,000$2,466,000dollars as filed
ORAMED PHARMACEUTICALS INC68403P203COM NEW844,496$2,465,928dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM1,306,490$2,221,033dollars as filed
ASTROTECH CORP046484309COM220,410$1,972,647dollars as filed
WINGSTOP INC COM974155103Stock800$1,829,000dollars as filedput
LENZ THERAPEUTICS INC52635N103COM63,916$1,427,244dollars as filed
KINNATE BIOPHARMA INC49705R105COM498,851$1,326,944dollars as filed
ORUKA THERAPEUTICS INC COM00211Y506Stock706,930$1,244,197dollars as filed
FORTE BIOSCIENCES INC34962G109COM1,761,702$1,226,497dollars as filed
Milestone Pharmaceuticals Inc59935V107COM606,145$1,085,000dollars as filed
VERRICA PHARMACEUTICALS INC92511W108COM180,000$1,065,600dollars as filed
LISATA THERAPEUTICS INC128058302COM284,669$888,167dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock50,100$881,259dollars as filed
VISTAGEN THERAPEUTICS INC92840H400COM150,000$792,000dollars as filed
NEXTCURE INC65343E108COM306,465$683,417dollars as filed
CALCIMEDICA INC38942Q202COM NEW160,424$667,364dollars as filed
ABERCROMBIE & FITCH CO CL A002896207Stock100$470,000dollars as filedput
Q32 BIO INC746964105Common Stock24,894$424,194dollars as filed
TALIS BIOMEDICAL CORP87424L207COM NEW42,743$374,001dollars as filed
ALLOVIR INC019818103COM200,464$151,330dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001754960-24-000175 superseded2024-04-23acceptance time not in the bulk data set
13F-HR/A 0001754960-24-000178this filing2024-04-24acceptance time not in the bulk data set